Randomized trial reports the crystal structure of a new compound, indicating its potential applications in chemistry.
C 20 H 25 NO 3 S, triclinic, <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" overflow="scroll"> <m:mrow> <m:mi>P</m:mi> <m:mover accent="true"> <m:mn>1</m:mn> <m:mo>̅</m:mo> </m:mover> </m:mrow> </m:math> (no. 2), a = 7.413(5) Å, b = 11.608(9) Å, c = 11.759(8) Å, α = 68.921(13)°, β = 80.784(12)°, γ = 77.454(13)°, V = 917.9(11) Å 3 , Z = 2, R gt ( F ) = 0.0663, w R ref ( F 2 ) = 0.2198, T = 296(2) K.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: